Search Results
Jun 29, 2026, 07:46 ET Farmmi, Inc. Announces Pricing of $3.0 Million Underwritten Public Offering
Brookman LLP is acting as U.S. counsel to Aegis Capital Corp.The offering is being made pursuant to an effective shelf registration statement on Form F-3 (No. 333-280348) previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective by the SEC on June 27, 2024. A final
More news about: Farmmi, Inc.
Jun 29, 2026, 07:30 ET Eisai to Showcase Alzheimer's Disease Portfolio with More Than 50 Presentations at the Alzheimer's Association International Conference® 2026 (AAIC®)
therapy. About ProtofibrilsProtofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of soluble Aβ, having a primary role in the cognitive decline associated with this progressive, debilitating condition.1 Protofibrils cause
More news about: Eisai Inc.
Jun 29, 2026, 07:15 ET Global M&A momentum builds in 2026 as megadeals surge, but acquirers confront a new AI "winner's paradox"--Bain & Company M&A Midyear Report
ambitions."Six questions for deal successAs AI changes how executives think about M&A, Bain's report poses six fundamental questions that will form the foundation for successful deals:Do we have a clear view of how AI impacts the deal thesis? Every deal thesis should
More news about: Bain & Company
Jun 29, 2026, 07:11 ET The Coolest Meet-Cute Yet: 7-Eleven, Inc. Celebrates 60 Years of Slurpee® by Setting Out to Spark More Anniversaries with the First-Ever Slurpee Date
a citrusy twist, the beverage blends bright citrus flavor with notes of sweet vanilla icing, giving fans a zesty lemon cake treat in frozen drink form.**** Fans can enjoy the limited-time flavor in the commemorative 60th Anniversary Slurpee Day cups and top off the frozen beverage with pink, green and
More news about: 7-Eleven, Inc.
Jun 29, 2026, 07:07 ET Modular Data Center Joint Development Agreement Signed Between PowerBank Corporation and Nodiac.ai
under "Forward-Looking Statements" and "Risk Factors" in the Company's most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions;
More news about: PowerBank Corporation
Jun 29, 2026, 07:06 ET Honeywell Aerospace completes spin-off from Honeywell Technologies and begins trading on Nasdaq
quarterly financial informationHoneywell Aerospace released select quarterly financial information for fiscal years 2024 and 2025 in a Form 8-K filed with the SEC.About Honeywell Aerospace Honeywell Aerospace (Nasdaq: HONA) is an independent global aerospace and defense
More news about: Honeywell Aerospace Inc.
Jun 29, 2026, 07:05 ET REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
Financial Condition and Results of Operations" sections of REGENXBIO's Annual Report on Form 10-K for the year ended December 31, 2025, and comparable "risk factors" sections of REGENXBIO's Quarterly Reports on Form 10-Q and other filings, which have been filed with the SEC and are available on the SEC's
More news about: REGENXBIO Inc.
Jun 29, 2026, 07:00 ET Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000®
Exchange Commission, including its Registration Statement on Form S-4 (File No. 333-288329), Registration Statement on Form S-1 (File No. 333-296653), its Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K. Should one or more of these risks or uncertainties
More news about: Z Squared Inc.
Jun 29, 2026, 07:00 ET Rocket Lab to Acquire Iridium in Historic Deal, Creating A Fully Vertically Integrated Space Powerhouse Primed for Growth
, as well as on Iridium's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 12, 2026 (the "2025 10-K") and certain of Iridium's Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. To the extent that holdings of Iridium's
More news about: Iridium Communications Inc.
Jun 29, 2026, 07:00 ET Rocket Lab to Acquire Iridium in Historic Deal, Creating A Fully Vertically Integrated Space Powerhouse Primed for Growth
, as well as on Iridium's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 12, 2026 (the "2025 10-K") and certain of Iridium's Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. To the extent that holdings of Iridium's
More news about: Iridium Communications Inc.
Jun 29, 2026, 07:00 ET TETRA TECHNOLOGIES INTRODUCES TETRA NEPTUNE Z-LITE DEEPWATER COMPLETIONS FLUID
assumptions, the Company refers you to its filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company does not undertake any obligation to update or revise forward-looking statements.
More news about: TETRA Technologies, Inc.
Jun 29, 2026, 07:00 ET Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
than expected; and other risk factors detailed in our Securities and Exchange Commission filings, including our most recent Form 10-K for the year ended December 31, 2025 and the Form 10-Q for the quarter ended March 31, 2026. Artivion does not undertake to update its forward-looking statements, whether
More news about: Artivion, Inc.
Jun 29, 2026, 07:00 ET Shoulder Innovations Announces Closing of up to $50 Million Credit Facility
information regarding the new credit facility and the refinancing of the Company's existing credit facility will be included in a Current Report on Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission.About Shoulder InnovationsShoulder Innovations
More news about: Shoulder Innovations
Jun 29, 2026, 07:00 ET Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
what's possible for patients living with I&I disorders."Additional information about the transaction will be provided in a Current Report on Form 8-K to be filed by JATT II with the Securities and Exchange Commission (the "SEC") and will be available at the SEC's website at
More news about: Talawar Therapeutics
Jun 29, 2026, 07:00 ET IsoEnergy Provides Update on Wildfire Activity Near Larocque East Project, Athabasca Basin
forward-looking statements are described in the risk factors in IsoEnergy's most recent annual management's discussion and analysis and annual information form and IsoEnergy's other filings with securities regulators which are available under the Company's profile on SEDAR+ at
More news about: IsoEnergy Ltd.
Jun 29, 2026, 06:55 ET Wheels Up Added to Russell 3000® and Russell 2000® Indexes
forward-looking statements can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (the "SEC") on March 11, 2025, the Company's Quarterly Report on Form 10-Q for the three months ended March 31, 2026 filed with the SEC
More news about: Wheels Up
Jun 29, 2026, 06:30 ET HONEYWELL TECHNOLOGIES LAUNCHES AS INDEPENDENT, PURE-PLAY AUTOMATION COMPANY FOLLOWING COMPLETION OF HONEYWELL AEROSPACE SPIN-OFF
shares are held in certificated form, upon the surrender of such shareowners' stock certificates.Supplemental Quarterly Information for Honeywell Technologies In connection with the spin-off, Honeywell Technologies will file a Current Report on Form 8-K later this morning presenting
More news about: Honeywell Technologies
Jun 29, 2026, 06:30 ET Collective Mining Discovers a New Tungsten Enriched High-Grade Subzone 300 Meters Below Surface at Apollo by Drilling 27.35 m at 37.55 g/t AuEq (1.68% WO3, 11.62 g/t Au, 54 g/t Ag, 0.43% Cu)
and approvals from government authorities); and title to properties, as well as those risk factors discussed or referred to in the annual information form of the Company dated March 30, 2026. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims
More news about: Collective Mining Ltd.
Jun 29, 2026, 06:10 ET Gabriel Marketing Group and Brandi AI Win Gold for Best Answer Engine Optimization Results in a PR Campaign in the 2026 Bulldog PR Awards
startups, scaleups and established technology companies clarify complex stories, build visibility and earn market credibility. As B2B technology buyers form opinions through media coverage, analyst commentary, thought leadership, third-party proof and AI-generated responses, GMG helps companies become easier
More news about: Brandi AI
Jun 29, 2026, 06:00 ET Accountants Combat Economic Uncertainty with Halfpricesoft.com's ezACH Direct Deposit Software
SolutionsBusinesses looking to further streamline operations can also utilize:ezPaycheck, a payroll software with unlimited check and form printing at one flat rate.ezCheckPrinting, a business check writing software for vendors, miscellaneous checks, and draft checks.ezAccounting,
More news about: Halfpricesoft.com
Jun 29, 2026, 06:00 ET THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT
forth in such proxy statements, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Beneficial Ownership on Form 4 filed with the SEC. Additional information regarding the identity of potential participants, and their direct and indirect
More news about: Theravance Biopharma, Inc.
Jun 29, 2026, 06:00 ET CLEAR to Strengthen Caller Verification in Contact Centers with AWS
described in the Company's filings within the Securities and Exchange Commission, including the sections titled "Risk Factors" in our Annual Report on Form 10- K. The Company disclaims any obligation to update any forward-looking statements contained herein.CLEAR
More news about: CLEAR
Jun 29, 2026, 04:47 ET Ever Supreme Launches Phase IIa Clinical Trial for CAR001, Accelerating Global Market Expansion
The clinical design of CAR001 offers a distinct, highly differentiated competitive advantage: patients do not need to undergo lymphodepletion, a form of preparatory chemotherapy, before receiving the cell infusion. Historically, this preparatory chemo was required to clear out immune-suppressing cells,
More news about: Ever Supreme Bio Technology Co., Ltd.
Jun 29, 2026, 04:25 ET Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP
6, 2026CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Immutep filed an SEC Form-K on January 30, 2026 that its TACTI-004 trial of eftilagimod alfa ("efti") was showing "strong operational progress." Despite this claim, the Company
More news about: DJS Law Group LLP
Jun 29, 2026, 03:15 ET IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm
and misleading statements to the market. Immutep concealed the results of its TACTI-004 trial of eftilagimod alfa's ("efti"). The Company claimed in a Form-K filed with the SEC on January 30, 2026, that the trial was demonstrating "strong operational progress." The Company was aware at that time that the
More news about: The Schall Law Firm